Abstract
The main effort of the laser-driven ion acceleration community is aimed to improve particle beam features (energy, charge, divergence, monochromaticity) and to demonstrate reliable approaches to be used for multidisciplinary applications. An ion acceleration target area based on unique laser capabilities is available at ELI-Beamlines (Extreme Light Infrastructure) in the Czech Republic; it is called ELIMAIA (ELI Multidisciplinary Applications of laser-Ion Acceleration) and aims to provide stable, fully characterized and tuneable beams of particles accelerated by multi-Petawatt-class lasers and to offer them to the user community for multidisciplinary applications. The ELIMAIA section dedicated to ion focusing, selection, characterization and irradiation is named ELIMED (ELI MEDical and multidisciplinary applications). Thanks to ELIMED, very high-dose-rate (around Gy/min) controlled proton and ion beams, with energy ranging from 5 to 250 MeV, will be transported up to an in-air section dedicated to absolute and relative dosimetry of the laser-generated ions. A transmission, dual-gap air ionisation chamber will allow an on-line, non-destructive characterization of the ion dose at the user sample irradiation point. The uncertainty in the final dose released onto the sample is expected to be well below 5$\%$. An ELIMED radiobiology pilot experiment is scheduled in 2021, during which in-vitro cell irradiations will be carried out with well-controlled proton beams. In this work, the status of the ELIMED/ELIMAIA beamline will be reported along with a complete description of the main dosimetric systems and of their calibrations carried out at conventional accelerators.
Highlights
Ion acceleration driven by pulsed laser-plasma sources is a rapidly emerging field of Physics resulting from recent highpower laser technology achievements in terms of ultra-high intensities (> 1021 W/cm2) reached on target
The objective of the laser-driven ion target area ELIMAIA (ELI Multidisciplinary Applications of laser-Ion Acceleration) at ELI-Beamlines (Extreme Light Infrastructure) is to provide beams of particles accelerated by petawatt-class lasers suitable for multidisciplinary applications
The ELI MEDical applications (ELIMED) dosimetry system is based on three main devices: a Secondary Electron Monitoring (SEM), a Multi-Gaps Ionization Chamber (MGIC), and a Faraday Cup (FC) for absolute dosimetry
Summary
Ion acceleration driven by pulsed laser-plasma sources is a rapidly emerging field of Physics resulting from recent highpower laser technology achievements in terms of ultra-high intensities (> 1021 W/cm2) reached on target. This has allowed us to explore extreme regimes of laser-matter interaction. In Europe, the interest in hadrontherapy has grown rapidly, and the first dual ion (carbon and protons) clinical facility in Heidelberg, Germany, started treating patients in 2009. A laser-plasma source offers the possibility of simultaneous delivery of particle (ions and electrons) and photon (X/gamma rays) beams, enabling hybrid approaches of interest to cancer therapy [6]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
